Literature DB >> 146332

Cystostatic efficacy of DNA-complexes of adriamycin, daunomycin, and actinomycin D. II. Comparative in vivo studies in an Ehrlich-ascites tumor.

S Seeber, R B Schilcher, K P Brucksch, J Käding, C G Schmidt.   

Abstract

The cytostatic efficacy of the antibiotics adriamycin, daunomycin and actinomycin D and of DNA-complexes of these compounds was compared in an Ehrlich ascites tumor in vivo. Various doses of the individual drugs and their DNA-complexes were injected intraperitoneally into female NMRI mice following 8 days after inoculation of 10(6) Ehrlich ascites cells. Survival analyses of animals demonstrated that by addition of DNA therapeutic indices were improved for adriamycin, daunomycin and actinomycin D, DNA alone had no effect on this tumor. Since earlier biochemical data (Seeber et al., 1977) had shown decreased in vitro cytotoxicity of DNA-bound antibiotics, this increase in therapeutic efficacy is probably due to an altered pharmacological behaviour after complex formation with a prolongation of effective intraperitoneal drug levels and decreased systemic toxicity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 146332     DOI: 10.1007/bf00284304

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  6 in total

1.  Experimental leukemia chemotherapy with a "lysosomotropic" adriamycin-DNA complex.

Authors:  A Trouet; D Deprez-de Campeneere; M de Smedt-Malengreaux; G Atassi
Journal:  Eur J Cancer       Date:  1974-07       Impact factor: 9.162

2.  Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L1210 leukemia.

Authors:  G Atassi; H J Tagnon
Journal:  Eur J Cancer       Date:  1974-07       Impact factor: 9.162

3.  Chemotherapy through lysosomes with a DNA-daunorubicin complex.

Authors:  A Trouet; D Deprez-de Campeneere; C De Duve
Journal:  Nat New Biol       Date:  1972-09-27

4.  Letter: DNA-daunorubicin complex: preliminary trials in human leukaemia.

Authors:  G Sokal; A Trouet; J L Michaux; G Cornu
Journal:  Eur J Cancer       Date:  1973-05       Impact factor: 9.162

5.  Potentiation of actinomycin D or adriamycin antitumor activity with DNA.

Authors:  T A Marks; J M Venditti
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

6.  Cytostatic efficacy of DNA-complexes of adriamycin, daunomycin and actinomycin D. I. Comparative studies in Novikoff hepatoma, human mammary carcinoma cells and human leukemic leukocytes.

Authors:  S Seeber; K P Brucksch; B Seeber; C G Schmidt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20
  6 in total
  2 in total

1.  Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex.

Authors:  B Andersson; I Andersson; M Beran; H Ehrsson; S Eksborg
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumor.

Authors:  T Skovsgaard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.